Annexin V expression and anti-annexin V antibodies in type 1 diabetes.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2014-01-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/jc.2013-2592PMID 24423325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.

  2012cited by this paper
• Autoimmune diseases and venous thromboembolism: a review of the literature.

  2012cited by this paper
• Risk of Subsequent Coronary Heart Disease in Patients Hospitalized for Immune-Mediated Diseases: A Nationwide Follow-Up Study from Sweden

  2012cited by this paper
• Inflammation and type one diabetes.

  2012cited by this paper
• Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study

  2011cited by this paper
• Clinical significance of anti-annexin V antibody in acute cerebral ischemia.

  2011cited by this paper
• Hyperglycemia: a prothrombotic factor?

  2010cited by this paper
• Diannexin Decreases Inflammatory Cell Infiltration Into the Islet Graft, Reduces &bgr;-Cell Apoptosis, and Improves Early Graft Function

  2010cited by this paper
• Inflammation, innate immunity and blood coagulation

  2010cited by this paper
• Juvenile diabetes mellitus--a risk factor for postoperative venous thromboembolism?

  2009cited by this paper
• Diabetes Mellitus and Risk of Venous Thromboembolism

  2009cited by this paper
• Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool

  2007cited by this paper
• Prognostic value of annexin A5 −1 C/T polymorphism in a long term follow‐up after premature myocardial infarction

  2007cited by this paper
• The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.

  2007cited by this paper
• Annexin V C/T-1 polymorphism and pregnancy complications.

  2006cited by this paper
• Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

  2005cited by this paper
• Anti-annexin V antibodies: are they prothrombotic?

  2005cited by this paper
• Antibodies against annexin A5: Detection pitfalls and clinical associations

  2005cited by this paper
• Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation

  2004cited by this paper
• Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.

  2004cited by this paper
• The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5.

  2003cited by this paper
• Diabetic Ketoacidosis Promotes a Prothrombotic State

  2003cited by this paper
• Unusual expression of the F9 gene in peripheral lymphocytes hinders investigation of F9 mRNA in hemophilia B patients

  2003cited by this paper
• Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies.

  2002cited by this paper
• A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients.

  2002cited by this paper
• Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities.

  2000cited by this paper
• Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.

  2000cited by this paper
• Anti-annexin V antibodies and digital ischemia in patients with scleroderma.

  1999cited by this paper
• Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.

  1998cited by this paper
• Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

  1997cited by this paper
• Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis

  1997cited by this paper
• Clinical significance of anti‐annexin V antibodies in patients with systemic lupus erythematosus

  1997cited by this paper
• Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

  1997cited by this paper
• Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V.

  1994cited by this paper
• Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.

  1994cited by this paper
• Clustering of lipid-bound annexin V may explain its anticoagulant effect.

  1992cited by this paper

• Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia.

  2025cites this paper
• FTO gene variants (rs17817449 and rs9939609) and novel leukocyte/Thrombocyte indexes as indicators of T2DM complications

  2025cites this paper
• “In House” assays for the quantification of Annexin V and its autoantibodies in patients with recurrent pregnancy loss and in vitro fertilisation failures

  2023cites this paper
• Utility of Platelet Derived Microparticles in Predicting Complications of Diabetes Mellitus

  2022cites this paper
• Relationship between the Soluble F11 Receptor and Annexin A5 in African Americans Patients with Type-2 Diabetes Mellitus

  2022cites this paper
• Increased endoglin levels correlated with angiogenesis‐associated angiopoietin‐2 in haemophilia patients

  2021cites this paper
• Serum Annexin V and Anti-Annexin V levels and their relationship with metabolic parameters in patients with type 2 diabetes.

  2019cites this paper
• Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.

  2019cites this paper
• Reduced Annexin A3 in schizophrenia

  2019cites this paper
• Annexin V expression on CD4+ T cells with regulatory function

  2019cites this paper
• Chapter 3 Annexin Proteins : Novel Promising Targets for Anticancer Drug Development

  2018cites this paper
• Annexin Proteins: Novel Promising Targets for Anticancer Drug Development

  2017cites this paper
• Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy.

  2016cites this paper
• Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis

  2015cites this paper
• Human umbilical cord blood derived mesenchymal stem cells were differentiated into pancreatic endocrine cell by Pdx-1 electrotransfer

  2014cites this paper